YB‐1 promotes transcription of cyclin D1 in human non‐small‐cell lung cancers M Harada, Y Kotake, T Ohhata, K Kitagawa, H Niida, S Matsuura, K Funai, ... Genes to Cells 19 (6), 504-516, 2014 | 61 | 2014 |
Aberrant expression and mutation-inducing activity of AID in human lung cancer K Shinmura, H Igarashi, M Goto, H Tao, H Yamada, S Matsuura, M Tajima, ... Annals of surgical oncology 18, 2084-2092, 2011 | 59 | 2011 |
RSPO fusion transcripts in colorectal cancer in Japanese population K Shinmura, T Kahyo, H Kato, H Igarashi, S Matsuura, S Nakamura, ... Molecular biology reports 41, 5375-5384, 2014 | 56 | 2014 |
Assessment of immune-related interstitial lung disease in patients with NSCLC treated with immune checkpoint inhibitors: a multicenter prospective study Y Suzuki, M Karayama, T Uto, M Fujii, T Matsui, K Asada, H Kusagaya, ... Journal of Thoracic Oncology 15 (8), 1317-1327, 2020 | 55 | 2020 |
Reduced expression of MUTYH with suppressive activity against mutations caused by 8‐hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer K Shinmura, M Goto, M Suzuki, H Tao, H Yamada, H Igarashi, S Matsuura, ... The Journal of pathology 225 (3), 414-423, 2011 | 55 | 2011 |
Clinicopathological and survival analysis of Japanese patients with resected non-small-cell lung cancer harboring NKX2-1, SETDB1, MET, HER2, SOX2, FGFR1, or PIK3CA gene … Y Inoue, S Matsuura, N Kurabe, T Kahyo, H Mori, A Kawase, M Karayama, ... Journal of Thoracic Oncology 10 (11), 1590-1600, 2015 | 46 | 2015 |
A novel tumor-derived SGOL1 variant causes abnormal mitosis and unstable chromatid cohesion T Kahyo, M Iwaizumi, K Shinmura, S Matsuura, T Nakamura, Y Watanabe, ... Oncogene 30 (44), 4453-4463, 2011 | 45 | 2011 |
SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers S Matsuura, T Kahyo, K Shinmura, M Iwaizumi, H Yamada, K Funai, ... Scientific reports 3 (1), 3012, 2013 | 37 | 2013 |
Evaluation of programmed death ligand 1 (PD-L1) gene amplification and response to nivolumab monotherapy in non–small cell lung cancer Y Inoue, K Yoshimura, K Nishimoto, N Inui, M Karayama, H Yasui, ... JAMA Network Open 3 (9), e2011818-e2011818, 2020 | 30 | 2020 |
CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma S Matsuura, K Shinmura, T Kamo, H Igarashi, K Maruyama, M Tajima, ... Oncology Reports 30 (4), 1675-1680, 2013 | 26 | 2013 |
Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting K Tanaka, N Inui, M Karayama, H Yasui, H Hozumi, Y Suzuki, K Furuhashi, ... Cancer Chemotherapy and Pharmacology 84, 147-153, 2019 | 23 | 2019 |
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer M Karayama, N Inui, Y Inoue, K Yoshimura, K Mori, H Hozumi, Y Suzuki, ... Cancer Immunology, Immunotherapy 71 (1), 203-217, 2022 | 21 | 2022 |
Genetic susceptibility to lung cancer H Sugimura, H Tao, M Suzuki, H Mori, M Tsuboi, S Matsuura, M Goto, ... Front Biosci (Schol Ed) 3, 1463-1477, 2011 | 21 | 2011 |
The geriatric nutritional risk index and prognostic nutritional index predict the overall survival of advanced non-small cell lung cancer patients S Matsuura, K Morikawa, Y Ito, T Kubota, K Ichijo, E Mochizuki, N Akiyama, ... Nutrition and Cancer 74 (5), 1606-1613, 2022 | 20 | 2022 |
Sarcopenia is associated with the Geriatric Nutritional Risk Index in elderly patients with poorly controlled type 2 diabetes mellitus S Matsuura, K Shibazaki, R Uchida, Y Imai, T Mukoyama, S Shibata, ... Journal of Diabetes Investigation 13 (8), 1366-1373, 2022 | 19 | 2022 |
Phase II study of erlotinib as third-line monotherapy in patients with advanced non-small-cell lung cancer without epidermal growth factor receptor mutations S Matsuura, N Inui, Y Ozawa, Y Nakamura, M Toyoshima, K Yasuda, ... Japanese Journal of Clinical Oncology 41 (8), 959-963, 2011 | 19 | 2011 |
Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma K Shinmura, H Tao, K Nagura, M Goto, S Matsuura, T Mochizuki, K Suzuki, ... Lung cancer 71 (1), 19-27, 2011 | 17 | 2011 |
Characterization of V‐set and immunoglobulin domain containing 1 exerting a tumor suppressor function in gastric, lung, and esophageal cancer cells Y Inoue, S Matsuura, K Yoshimura, Y Iwashita, T Kahyo, A Kawase, ... Cancer science 108 (8), 1701-1714, 2017 | 16 | 2017 |
Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report M Harada, H Naoi, K Yasuda, Y Ito, N Kagoo, T Kubota, K Ichijo, ... BMC Pulmonary Medicine 21, 1-6, 2021 | 14 | 2021 |
A novel somatic FGFR3 mutation in primary lung cancer K Shinmura, H Kato, S Matsuura, Y Inoue, H Igarashi, K Nagura, ... Oncology reports 31 (3), 1219-1224, 2014 | 14 | 2014 |